Substance
NADROPARIN
Global reference: every product and company linked to this substance.
- cas: 9005-49-6
- ncit: C200713
- ncit: C78447
- ncit: C223464
- ncit: C87297
- ncit: C142899
- ncit: C1452
- ncit: C1453
- ncit: C539
- ncit: C221856
- rxnorm: 67031
- rxnorm: 2368733
- rxnorm: 75960
- rxnorm: 69646
- rxnorm: 67108
- rxnorm: 69528
- rxnorm: 1856273
- rxnorm: 67109
- rxnorm: 5224
- rxnorm: 152610
- rxnorm: 87866
- unii: 1K5KDI46KZ
- unii: 4QW4AN84NQ
- unii: 5R0L1D739E
- unii: 7UQ7X4Y489
- unii: 9816XA9004
- unii: E47C0NF7LV
- unii: M316WT19D8
- unii: P776JQ4R2F
- unii: S79O08V79F
- unii: T2410KM04A
- unii: V72OT3K19I
- unii: VL0L558GCB
ADOMIPARIN [USAN] · Adomiparin [WHO-DD] · Ardeparin [WHO-DD] · B01AB04 · B01AB10 · Dalteparin [WHO-DD] · Enoxaparin [WHO-DD] · Heparin [WHO-DD] · Heparin porcine [WHO-DD] · M-118 · Nadroparin [WHO-DD] · Parnaparin [WHO-DD]
Revenue by product (0)
No revenue reported for this substance in loaded filings.
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.